Market
Pathologists play a central role in healthcare: they examine and diagnose patient samples to guide medical treatment. But aging populations and rising disease rates are putting unprecedented strain on healthcare systems worldwide. Annual global cancer incidence is projected to rise by 77%, from 20 million cases in 2022 to over 35 million by 2050. This is driven largely by demographic change, as the share of the world’s population aged 65 and older grows from 9.3% in 2020 to 16.0% in 2050.
Each case is also becoming more demanding. Between 2006 and 2014, the number of slides per pathology case rose by 60%, as laboratories took more tissue biopsies and more slides per biopsy. Over the same period, immunohistochemistry slides per case nearly doubled and molecular testing more than tripled, driven by precision-medicine diagnostics.
This adds a heavy burden to a workforce that is already stretched. The US alone faces a projected shortage of 3,520 full-time equivalent (FTE) pathologists by 2038. In the UK, 47% of pathologists are expected to retire within 10 years. Legacy tools make the gap wider: manual slide analysis with traditional microscopes is slow, labor-intensive and prone to variability.
The digital transformation in pathology is under way as the digitisation of glass slides traditionally examined under a microscope to now be analysed on a computer, is becoming increasingly prevalent in labs and hospitals across the world in an effort to modernise the diagnostic workflow. Digital pathology has paved the way for even more advanced technology like AI.
AI can help healthcare systems meet the challenges. AI-based image analysis makes sample review more consistent and less subjective, while improving speed and accuracy. It supports pathologists in their work and enables precision diagnostics. This can help patients get diagnoses faster, enable more personalized treatment, and widen access to expert diagnostics.
Increasing rates of disease like cancer, population aging, and the rising prevalence of chronic conditions are fueling the demand for pathology analysis.1
The shortage of pathologists has been detected in certain areas of the medical industry. This, combined with increased sample volume, could lead to pathologists being overworked. For example, in a study conducted in the United Kingdom in 2018, 97% of histopathology institutions indicated they faced a shortage of personnel resources to a certain degree in order to meet clinical demand.2
Expansion in digital pathology is widespread, as the adoption of microscope scanners to convert samples into digital images increases, enabling laboratories to adopt AI. Global pathology slide digitalization rate in 2029 is estimated to reach 51%.3
Technological development and therefore growing adoption of digital pathology solutions to enhance lab efficiency and to address the critical shortage of pathologists, opening up the market to AI-assisted solutions.
Targeted cancer therapies depend on biomarker testing, so pharma is bringing AI-based biomarker analysis from drug development into routine diagnostics.
1WHO/IARC GLOBOCAN 2022 (published 2024)
2The Royal college of pathologists: Histopathology workforce census 17/18
3Customized Global Microscope Slide Industry Market Research Report 2024
